glp-1 muscle wasting Glucagon-like peptide-1 receptor agonists and mass effects GLP-1 Muscle Loss: The Fear
Description
Donors should report any history of fainting, dizziness upon standing, or cardiovascular symptoms to medical staff before proceeding with donation
The Australian obesity management algorithm: a simple tool to guide the management of obesity in primary care
Foundayo is also not approved for use in children
Following our initial search, we identified five additional articles which met our inclusion criteria, bringing the total to 46 studies which were included in this review
2023 May 24;18(1):381
